Guilin Sanjin Pharmaceutical Co Ltd (002275) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Guilin Sanjin Pharmaceutical Co Ltd (002275) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.62 Million ≈ $17.21 Million USD) by net assets (CN¥3.24 Billion ≈ $474.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guilin Sanjin Pharmaceutical Co Ltd (002275) market capitalisation for the company's overall valuation and market capitalisation.

Guilin Sanjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Guilin Sanjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guilin Sanjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guilin Sanjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Guilin Sanjin Pharmaceutical Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
CRA International Inc
NASDAQ:CRAI
-0.024x
Hengtong Logistic Co Ltd
SHG:603223
-0.077x
Metsa Board Oyj B
HE:METSB
-0.005x
BLS International Services Limited
NSE:BLS
0.211x
Compass Minerals International Inc
NYSE:CMP
0.618x
Top Energy Shanxi Co Ltd
SHG:600780
0.054x
Hotel Shilla
KO:008770
-0.137x
KRN Heat Exchanger and Refrigeration
NSE:KRN
0.107x

Annual Cash Flow Conversion Efficiency for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. View 002275 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.01 Billion
≈ $440.42 Million
CN¥588.33 Million
≈ $86.09 Million
0.195x +0.25%
2023-12-31 CN¥2.82 Billion
≈ $412.21 Million
CN¥549.25 Million
≈ $80.37 Million
0.195x +3.76%
2022-12-31 CN¥2.81 Billion
≈ $411.68 Million
CN¥528.67 Million
≈ $77.36 Million
0.188x +30.08%
2021-12-31 CN¥2.84 Billion
≈ $415.55 Million
CN¥410.24 Million
≈ $60.03 Million
0.144x -28.52%
2020-12-31 CN¥2.96 Billion
≈ $433.00 Million
CN¥597.99 Million
≈ $87.50 Million
0.202x +21.50%
2019-12-31 CN¥2.82 Billion
≈ $411.99 Million
CN¥468.29 Million
≈ $68.52 Million
0.166x -15.39%
2018-12-31 CN¥2.81 Billion
≈ $410.70 Million
CN¥551.73 Million
≈ $80.73 Million
0.197x +34.52%
2017-12-31 CN¥2.65 Billion
≈ $388.35 Million
CN¥387.82 Million
≈ $56.75 Million
0.146x -33.97%
2016-12-31 CN¥2.43 Billion
≈ $354.94 Million
CN¥536.85 Million
≈ $78.56 Million
0.221x +30.14%
2015-12-31 CN¥2.34 Billion
≈ $342.87 Million
CN¥398.50 Million
≈ $58.31 Million
0.170x -0.47%
2014-12-31 CN¥2.32 Billion
≈ $339.57 Million
CN¥396.53 Million
≈ $58.02 Million
0.171x +19.83%
2013-12-31 CN¥2.20 Billion
≈ $322.38 Million
CN¥314.16 Million
≈ $45.97 Million
0.143x -2.08%
2012-12-31 CN¥2.08 Billion
≈ $304.06 Million
CN¥302.59 Million
≈ $44.28 Million
0.146x -15.34%
2011-12-31 CN¥1.98 Billion
≈ $290.15 Million
CN¥341.05 Million
≈ $49.91 Million
0.172x +8.44%
2010-12-31 CN¥1.80 Billion
≈ $263.37 Million
CN¥285.49 Million
≈ $41.78 Million
0.159x -22.16%
2009-12-31 CN¥1.78 Billion
≈ $260.89 Million
CN¥363.29 Million
≈ $53.16 Million
0.204x -16.01%
2008-12-31 CN¥787.10 Million
≈ $115.18 Million
CN¥190.97 Million
≈ $27.94 Million
0.243x +7.63%
2007-12-31 CN¥729.25 Million
≈ $106.71 Million
CN¥164.39 Million
≈ $24.06 Million
0.225x -35.03%
2006-12-31 CN¥627.33 Million
≈ $91.80 Million
CN¥217.67 Million
≈ $31.85 Million
0.347x --

About Guilin Sanjin Pharmaceutical Co Ltd

SHE:002275 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.06 Billion
CN¥7.26 Billion CNY
Market Cap Rank
#8699 Global
#2080 in China
Share Price
CN¥12.36
Change (1 day)
+0.49%
52-Week Range
CN¥12.08 - CN¥15.61
All Time High
CN¥19.61
About

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache … Read more